Story
-
Accuknox — Dramatically enhancing cloud-based cybersecurity for large enterprises and open-source applications
SRI spin-out, Accuknox, uses high-performance runtime zero trust container to protect applications, networks and data.
-
SRI awarded $23 million contract for education research partnerships across Kentucky, Tennessee, Virginia and West Virginia
SRI Education has been awarded a five year contract to fund the continued leadership of the Regional Educational Laboratory (REL) Appalachia.
-
Featured innovator: Indira Jayaweera
A senior program manager whose curiosity captures carbon.
-
SRI research points to a tripling of depression risk in emerging adults during the pandemic
Study shows young women are particularly impacted.
-
SRI International announces collaboration agreement with Janssen
Collaboration focuses on SRI’s Synfini artificial intelligence and automation platform to accelerate small-molecule drug discovery.
-
Jesse Wodin talks about quantum at SRI
Join us to learn how the applications of quantum mechanics are poised to revolutionize the worlds of engineering, sensing, computing, metrology and communications, and how SRI is emerging as a global leader and innovator in applied quantum sciences.
-
New AI engine to help people accelerate data-driven discovery
Novel AI approach integrates data-driven modeling with theoretical reasoning to construct sophisticated deep learning architectures
-
2021 — A year in review
Throughout 2021, SRI has continued to focus on its core mission of making the world safer, healthier and more productive.
-
Nomura-SRI Innovation Center welcomes new members and plans to increase membership in 2022
The Nomura-SRI innovation center (NSIC) announced today that they will be welcoming several major member additions.
-
QED-C takes vital steps to create the full quantum computing stack from hardware to applications
Coordinating interoperability across the sets of quantum compiler toolchains.
-
SRI Bioscience awarded $14.7 million contract to continue development of high-concentration Naloxone formulation
SRI Biosciences has been awarded a contract sponsored by the Defense Threat Reduction Agency (DTRA) to continue development of a high-concentration naloxone product.
-
75 Years of Innovation: Computer vision
Blurring the lines between humans and computers.